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Abstract
Introduction: This prospective study investigated whether plasma ionized calcium concentration abnormalities and
other electrolyte disturbances represent risk factors for the development of critical illness polyneuromyopathy
(CIPNM) in ICU patients.
Methods: One hundred and ninety consecutive adult critically ill patients with prolonged ICU stay (longer than 7
days) were prospectively evaluated. Patients with acute weakness and/or weaning difficulties were subjected to
extensive electrophysiological measurements in order to establish the diagnosis of CIPNM. All recognized and/or
possible risk factors for development of CIPNM were recorded.
Results: The diagnosis of CIPNM was confirmed in 40 patients (21.05%). By applying a logistic regression model,
hypocalcemia (P = 0.02), hypercalcemia (P = 0.01) and septic shock (P = 0.04) were independently associated with
the development of CIPNM in critically ill patients.
Conclusions: We found that septic shock and abnormal fluctuations of plasma Ca
2+ concentration represent
significant risk factors for the development of CIPNM in critically ill patients.
Introduction
Acutely acquired neuromuscular dysfunction is a com-
mon phenomenon among critically ill patients in the
ICU, with a prevalence ranging between 25 and 60%
depending upon the criteria used for the diagnosis, the
population studied and the timing of examination [1].
Critical illness polyneuropathy and critical illness myo-
pathy have been established as separate entities of mus-
cular weakness leading to considerable weaning
difficulties and prolonged ICU stay. These two entities
often coexist [2] and have been related to systemic
inflammatory response syndrome and sepsis [3]. Several
risk factors, such as the administration of neuromuscu-
lar blocking agents, aminoglycosides and high-dose cor-
ticosteroids, have so far frequently but controversially
been considered [4-7].
In recent years there has been considerable interest in
the role of intracellular calcium homeostasis
disturbances as an early event leading to cell injury or
death. Calcium is an important intracellular messenger
and regulator of cell function. Calcium is essential for
the excitation-contractionc o u p l i n gi nm u s c l e ,n e u r o -
transmission, digestive enzyme activation, inhibition of
ATP synthesis and free radical production. Intracellular
Ca
2+ homeostasis of skeletal muscle fibers in mice is
altered during sepsis and this has been implicated in the
pathogenesis of critical illness polyneuropathy/myopathy
(CIPNM) [8].
Very little is known regarding the association of extra-
cellular calcium concentration abnormalities with the
development of neuromuscular dysfunction in critically
ill patients. This lack of information is surprising, as
ionized hypocalcemia or hypercalcemia are not uncom-
mon in patients treated in ICUs and have been shown
to correlate with increased mortality [9]. It has long
been established that patients with chronic hypocalce-
mia due to parathyroid gland hypofunction may develop
myopathy, and moreover the degree of change in mus-
cles has been found to be related to the severity of
hypocalcemia [10,11]. The exact pathophysiological
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been elucidated. There is also experimental evidence
from an animal model that a reduced Ca
2+ plasma con-
centration elevates creatine kinase due to skeletal mus-
cle injury [12]. Also, chronic hypercalcemia that
develops secondary to hyperparathyroidism produces
many psychiatric and cognitive symptoms, as well as a
reversible myopathy [13].
The present study investigated several possible risk
factors associated with the development of CIPNM in
critically ill patients. Special emphasis was given to
patients’ plasma ionized calcium concentration fluctua-
tions and other serum electrolyte abnormalities since
they alter membrane excitability.
Materials and methods
One hundred and ninety consecutive patients were pro-
spectively enrolled in the study protocol. The patients
were evaluated on a daily basis during a 9-month period
(from January 2008 to October 2008) in the 24-bed mul-
tidisciplinary ICU of Henry Dunant Hospital, Athens,
Greece.
The study protocol was approved by the Ethics and
Research Committee of Henry Dunant Hospital. All of
the procedures used were in accordance with the
recommendations found in the Helsinki Declaration of
1975. There was no change made during the study per-
iod to personnel, surgical procedure, protocol for gen-
eral anesthesia or management of patients in the ICU.
For this reason, a consent form was not obtained.
Included as participants were adult patients (age > 18
years old) who remained hospitalized in the ICU for
more than 7 days, independent of cause. Excluded were
patients with pre-existing neuromuscular and renal dis-
ease as well as those with adrenal insufficiency and cal-
cium metabolism dysfunction.
Study protocol
The data collected prospectively for each patient included
demographics, medical history, and several variables
thought to be associated with the pathogenesis of CIPNM
- such as Acute Physiology and Chronic Health Evaluation
II score recorded on the eighth ICU day, Sequential Organ
Failure Assessment score recorded on the first day of doc-
umentation of nosocomial infection and/or sepsis syn-
drome, development of sepsis syndrome, and
administration of aminoglycosides, corticosteroids, ino-
tropes or neuromuscular blocking agents for more than 1
day. Serum ionized Ca
2+ concentrations, serum Na
+ and K
+ concentrations, serum glucose levels and arterial blood
pH included in the routine laboratory set were recorded
every 3 hours from the first ICU day. These variables were
analyzed by means of an ABL 800 FLEX Blood Gas Analy-
zer (Radiometer, Copenhagen, Denmark). Serum ionized
Ca
2+ concentrations and pH values were corrected for pH
7.40. In addition, we recorded all complications that
occurred during the ICU stay, the length of the ICU stay,
the patient’s outcome (death or discharge), and the cause
of any death. The above variables were evaluated daily
until either CIPNM was diagnosed or the patient was dis-
charged from the ICU.
The tested risk factors for CIPNM were chosen a
priori by investigator consensus and based on published
articles until December 2007.
Every patient was evaluated once daily for muscle
weakness. In cooperative patients, 12 muscle groups
were assessed: wrist flexion, forearm flexion, shoulder
abduction, knee extension, hip flexion and foot exten-
sion. Patients with brain injury or these too heavily
sedated to understand simple orders were tested by
evaluating the muscle tone. When weaning difficulties
appeared (that is, when patients were unable to be defi-
nitely released from mechanical ventilation) and/or the
flaccid weakness was bilateral, involving upper and
lower extremities (resulting in more than 20% reduction
of the Medical Research Council score in cooperating
patients) [14], extensive electrophysiological investiga-
tions were undertaken. All patients showing clinical fea-
tures of CIPNM (for example, weaning difficulty or
flaccid weakness in upper and low extremities) were
assessed by electromyography screening.
Electrolyte disturbances were corrected by the intensi-
vists, independently of the study protocol. Cut-off values
were considered for ionized Ca
2+ < 0.9 mmol/l, Na
+ <
130 mmol/l, and K
+ < 3.4 mmol/l. The correction of
electrolyte disturbances was made by senior intensivists,
who were blinded to study parameters, with intravenous
administration of electrolyte solutions such as CaCl2 (10
ml of 10%) and KCl (10 ml of 10%).
Definitions
The diagnosis of CIPNM was confirmed by markedly
reduced and often prolonged compound muscle action
potentials (peroneal and ulnar nerves bilaterally) and
abundant, widespread spontaneous activity with fibrilla-
tion potentials and positive sharp waves on conventional
needle electromyography [15]. Motor unit potentials
were in most cases polyphasic, of low amplitude and
short duration (myopathic). Both peripheral and proxi-
mal muscles of the upper and lower extremities were
investigated (tibialis anterior, vastus lateralis, deltoideus,
and interosseus dorsalis I). No attempt was made to dif-
ferentiate between neuropathy and myopathy by directly
stimulating the muscles. Entrapment syndromes, espe-
cially at the elbow, did not represent a matter of con-
cern in establishing the diagnosis because conduction
velocity slowing and electromyography findings were
expected to be locally isolated.
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if they had lasted at least 36 hours. Normal values were
considered 1.16 to 1.30 mmol/l for ionized Ca
2+,1 3 4t o
149 mmol/l for ionized Na
+, and 3.5 to 5.4 mmol/l for
ionized K
+ [16]. Acute hyperglycemia was defined as
serum glucose levels above 180 mg/dl [17]. Sepsis syn-
drome and septic shock were defined based on standard
criteria [18].
Statistical analysis
The data were analyzed using SPSS 17 for Windows
(SPSS Inc., Chicago, IL, USA). The differences were cal-
culated using Fisher’s exact test for dichotomous or
categorical variables and the two-sample Wilcoxon test
for continuous variables. A backward stepwise regres-
sion analysis was used to identify the set of independent
variables that contributed significantly to the fit of the
model (removing criterion, P > 0.20). When a multilevel
categorical variable was found to be significant, tests
were conducted to determine whether some levels could
be combined. The dependent variable was binary, with
one denoting CIPNM and zero denoting no develop-
ment of CIPNM. Values are reported as number (per-
centage), mean ± standard deviation, or median
(interquartile range) as appropriate. Significance was set
at P < 0.05. All reported P values are two-sided.
Results
Out of 968 patients admitted to the ICU during the
study period (690 males, 278 females, mean age 65.5 ±
14.8), 40 patients (4.1%) developed CIPNM. In the sub-
group of critically ill patients with ICU length of stay
longer than 7 days (n = 190, 66.8% males) and mean age
66.9 ± 15.4 years, 40 patients (21%) developed CIPNM.
The main causes of ICU admission for patients with
prolonged ICU length of stay (n = 190) are presented in
T a b l e1 .T h em e a nA c u t eP h y s i o l o g ya n dC h r o n i c
Health Evaluation II and Sequential Organ Failure
Assessment scores for all patients (n =1 9 0 )w e r e2 1 . 7±
7.0 and 7.9 ± 4.1, respectively. Out of 190 patients
enrolled in the study protocol, 142 patients (74.7%)
improved and were discharged from the ICU. The med-
ian ICU length of stay of survivors (n =1 4 2 )w a s1 6
days. No patient in the subgroup of patients with length
of ICU stay shorter than 7 days developed CIPNM.
In the group of patients who developed a documented
CIPNM during their ICU stay, the length of mechanical
ventilation was 32.88 ± 22.2 days - compared with 14.4
± 9.0 days for patients with prolonged ICU stay (n =
150) who did not develop CIPNM (P < 0.05). Thirteen
out of 40 patients (32.5%) with CIPNM died in the ICU.
The mean length of ICU stay of survivors (n =2 7 )w a s
30.7 ± 18.5 days.
During the episodes of prolonged hypocalcemia or
hypercalcemia, the ionized Ca
2+ serum concentration var-
ied between 0.33 and 1.14 mmol/l and between 1.35 and
1.53 mmol/l, respectively. Severe hypocalcemia (ionized
Ca
2+ serum concentration < 0.90 mmol/l) was found in 13
patients. The first episode of hypocalcemia occurred
within the first few days in the ICU (median ICU length of
stay 2 days, upper quartile 7 days; Figure 1). All of these
episodes occurred a few days prior the development of
CIPNM. The time points of hypocalcemia and CIPNM
diagnosis did not, however, correlate significantly.
Episodes of prolonged hypocalcemia were recorded in
101 out of 126 patients with septic shock. Of these
patients (n = 126), 33 patients (26.19%) developed CIPNM.
Univariate statistical analysis showed that among the
15 variables examined as possible risk factors for devel-
opment of CIPNM in critically ill patients five variables
were significant. For these risk factors, logistic regres-
sion analysis showed that hypocalcemia, hypercalcemia
and septic shock were major determinants significantly
and independently associated with the development of
CIPNM in adult patients in the ICU (Table 2).
Table 1 Causes of ICU admission for 190 patients
Cause Number of patients
Heart failure 28
Chronic obstructive pulmonary disease 25
Infection 39
Cerebrovascular event 15
Trauma 8
Postoperative support 55
Other 20
Figure 1 Emergence of the first episode of prolonged
hypocalcemia. Time point of emergence of the first episode of
prolonged hypocalcemia in 37 patients who developed critical
illness polyneuromyopathy.
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further explored by identifying a group of patients con-
taining those most severely affected (Sequential Organ
Failure Assessment score ≥9, n = 76). Hypocalcemia was
found to be significantly related to the development of
CIPNM (P = 0.03). Thus, only one patient with more
severe critical illness but normal plasma calcium levels
developed CIPNM (Figure 2A). In contrast, approximately
one-third of hypocalcemic patients belonging to this
group of severely affected patients developed CIPNM.
The severity of hypocalcemia, however, did not corre-
late with the severity of CIPNM. Noticeably, seven out
of the 13 patients with severe hypocalcemia (lower than
0.90 mmol/l) did not develop CIPNM and the mean Ca
2
+ concentration during the episode of hypocalcemia in
patients with CIPNM was not significantly lower than in
those without CIPNM (Figure 3).
The diagnosis of CIPNM was confirmed several days
(mean ICU length of stay 15.8 ± 6.0) after ICU admission.
Discussion
In this original study, we found that septic shock and
hypocalcemia represent significant risk factors for the
development of CIPNM in adult critically ill patients.
Ionized hypocalcemia has been shown to represent a
common laboratory abnormality among critically ill
patients and to be associated with increased mortality
[8,19]. Our prospective study, based on a large unse-
lected patient population of a mixed medical-surgical
ICU, demonstrated that hypocalcemia represents a sig-
nificant predisposing factor for the development of
CIPNM.
On the other hand, both ionized hypocalcemia and
CIPNM may be related to sepsis syndrome. One might
Table 2 Risk factors for development of critical illness polyneuromyopathy
Variable Patients with CIPNM (n = 40) Patients without CIPNM (n = 150) P value
Age 68.7 ± 15.7 66.4 ± 15.9 0.55
Female gender 24 39 0.002
APACHE II score 23.7 ± 6.5 20.1 ± 7 0.04
SOFA score 8.4 ± 4.1 7.8 ± 4.2 0.16
Aminoglucosides 20 52 0.18
Corticosteroids 28 102 0.84
NMBA 16 40 0.35
Septic shock 33 93 0.04
Hyperglycemia 10 43 0.66
Hyperkalemia 0 1 1
Hypokalemia 5 14 0.49
Hypernatremia 6 9 0.14
Hyponatremia 7 30 0.89
Hypercalcemia 4 3 0.01
Hypocalcemia 37 114 0.02
APACHE, Acute Physiology and Chronic Health Evaluation; CIPNM, critical illness polyneuromyopathy; NMBA, neuromuscular blocking agents; SOFA, Sequential
Organ Failure Assessment.
Figure 2 Episodes of prolonged hypocalcemia or hypercalcemia in ICU patients. A Patients with more severe critical illness (Sequential
Organ Failure Assessment (SOFA) ≥9, n = 76) but normal plasma Ca
2+ concentration did not develop critical illness polyneuromyopathy (CIPNM).
In contrast, CIPNM was frequently observed in patients of the same group presenting with hypocalcemia. B Hypocalcemia/CIPNM cases in all
190 patients.
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Ca
2+ concentration are not the cause but simply a con-
sequence of severe sepsis not directly related to CIPNM.
Alternative explanations cannot be excluded, however,
as their relationship was confirmed equally in a sub-
group of more severely affected patients.
One of the proposed mechanisms for hypocalcemia is
influx and intracellular accumulation of calcium ions
[20]. Increased concentrations of Ca
2+ into muscle cells
may represent the critical link in the pathophysiology of
CIPNM; proteolysis of myofibrillar structure proteins,
mainly myosin thick filaments, is dependent on Ca
2+
release from intracellular stores as the administration of
dantrolene is able to block this response to sepsis in rat
skeletal muscle [21].
Muscle membrane hypoexcitability has been recently
associated with sepsis, and may be implicated with the
development of CIPNM [22]. Hypocalcemia increases
neuronal membrane excitability by reducing the thresh-
old of voltage-dependent Na
+ channel activation [23]
and by directly interacting with channel gating machin-
ery [24]. In CIPNM muscle membrane, however, excit-
ability is reduced. Noticeably, the molecular mechanisms
by which Ca
2+ may affect muscle membrane excitability
and the signals it may convey to the cell interior (that
is, by means of extracellular calcium-sensing receptors)
are, in contrast to the extensively studied intracellular
actions, less well investigated.
Apart from persistent hypocalcemia, we found that sep-
tic shock was strongly correlated with the development of
CIPNM in ICU patients. This finding is in accordance
with previous original studies [25-27]. Among several
other risk factors implicated, diabetes mellitus seems to
play a crucial role in critical illness polyneuropathy/
critical illness myopathy. Bird reports that intensive insu-
lin therapy in diabetic patients in the ICU appears to
reduce the likelihood of developing CIPNM [28]. On the
other hand, Rich and colleagues showed that high-dose
corticosteroids and a number of factors seem to modify
membrane excitability [29,30]. This effect has been
attributed to a shift in the voltage dependence of sodium
channel fast inactivation towards more negative poten-
tials in conjunction with depolarization of the resting
membrane potential. Reduced sodium channel availabil-
ity has also been shown by investigating muscle mem-
brane excitability in CIPNM with velocity recovery cycles
[31]. One should note, however, that persistent serum
hypocalcemia acts in the neuronal membrane by means
of an unknown pathophysiological mechanism.
Not only hypocalcemia but also prolonged hypercalce-
mia were found to be significant predisposing factors in
our study. This observation may be not completely sur-
prising, as chronic elevation of Ca
2+ plasma concentration
in primary hyperparathyroidism may result in muscle
weakness [32]. Hypercalcemia may also result as a conse-
quence of malignancy, infections or immobilization. In a
consecutive series of 100 cases with primary hyperpar-
athyroidism, patients with neuromuscular symptoms had
significantly higher plasma calcium levels than the rest of
the group [33]. The mechanism and pathology of these
symptoms have not yet been elucidated. Consequently,
since prolonged hypercalcemia was relatively infrequent in
our patient group, we feel that its exact significance should
be examined in larger patient populations.
Conclusions
We found that septic shock and hypocalcemia represent
independent risk factors for the development of CIPNM
in critically ill patients. Future research may be war-
ranted to confirm these findings in larger patient popu-
lations and to investigate the molecular mechanism
linking extracellular with intracellular calcium homeos-
tasis abnormalities.
Key messages
￿ Long-lasting decreased levels of plasma Ca
2+ con-
centration are significantly correlated with CIPNM
in adult patients in the general ICU.
￿ Apart from hypocalcemia, septic shock represents
another significant risk factor for ICU-acquired
CIPNM.
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